Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals.
Background Recent reports have suggested that among individuals previously infected with
SARS-CoV-2, a single mRNA vaccine dose is sufficient to elicit high levels of immunity …
SARS-CoV-2, a single mRNA vaccine dose is sufficient to elicit high levels of immunity …
Mast cell activation is associated with post‐acute COVID‐19 syndrome
JB Wechsler, M Butuci, A Wong, AP Kamboj… - Allergy, 2021 - pmc.ncbi.nlm.nih.gov
To the Editor, As of July 2021, over 30-million Americans have recovered from documented
COVID-19 infection, and prevalence studies suggest up to twice as many may be …
COVID-19 infection, and prevalence studies suggest up to twice as many may be …
COVID-19 underreporting and its impact on vaccination strategies
Background Underreporting cases of infectious diseases poses a major challenge in the
analysis of their epidemiological characteristics and dynamical aspects. Without accurate …
analysis of their epidemiological characteristics and dynamical aspects. Without accurate …
Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
Two-dose messenger RNA vaccines against the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 …
coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 …
COVID-19 mRNA vaccination generates greater immunoglobulin G levels in women compared to men
AR Demonbreun, A Sancilio, ME Velez… - The Journal of …, 2021 - academic.oup.com
We investigated whether the antibody response to coronavirus disease 2019 (COVID-19)
mRNA vaccination is similar in women and men. In a community cohort without prior COVID …
mRNA vaccination is similar in women and men. In a community cohort without prior COVID …
COVID-19 symptom severity predicts neutralizing antibody activity in a community-based serological study
Serological testing for SARS-CoV-2 IgG antibodies is used to assess their presence in blood
samples from exposed individuals and provides a measure of the magnitude of immune …
samples from exposed individuals and provides a measure of the magnitude of immune …
A large series of molecular and serological specimens to evaluate mother-to-child SARS-CoV-2 transmission: a prospective study from the Italian Obstetric …
EC Decenti, MA Salvatore, A Mancon, G Portella… - International Journal of …, 2023 - Elsevier
Objectives To assay the presence of the SARS-CoV-2 genome in vaginal, rectal, and
placental swabs among pregnant women and in newborn nasopharyngeal swabs and to …
placental swabs among pregnant women and in newborn nasopharyngeal swabs and to …
Unique molecular signatures sustained in circulating monocytes and regulatory T cells in convalescent COVID-19 patients
AD Hoffmann, SE Weinberg, S Swaminathan… - Clinical …, 2023 - Elsevier
Over two years into the COVID-19 pandemic, the human immune response to SARS-CoV-2
during the active disease phase has been extensively studied. However, the long-term …
during the active disease phase has been extensively studied. However, the long-term …
Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohort
Background The true incidence of SARS-CoV-2 infection in Costa Rica was likely much
higher than officially reported, because infection is often associated with mild symptoms and …
higher than officially reported, because infection is often associated with mild symptoms and …
A dried blood spot protocol for high-throughput quantitative analysis of SARS-CoV-2 RBD serology based on the Roche Elecsys system
N Castelletti, I Paunovic, R Rubio-Acero… - Microbiology …, 2024 - Am Soc Microbiol
ABSTRACT SARS-CoV-2 spreads pandemically since 2020; in 2021, effective vaccinations
became available and vaccination campaigns commenced. Still, it is hard to track the spread …
became available and vaccination campaigns commenced. Still, it is hard to track the spread …